Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...

GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

Leading clinicians, researchers & pharmaceutical innovators gathered to discuss the future of cancer treatment.

Lifecore Biomedical and PolyPeptide Laboratories have linked to deliver an end-to-end peptide manufacturing solution for US ...

In the complex and challenging field of early-phase clinical trials, logistics specialists are vital. A recent podcast spoke ...

MHLW of Japan has granted orphan regenerative medicine product designation to Kyowa Kirin and Orchard Therapeutics’ MLD therapy..

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

The foremost geopolitical rivalry between the US and China is increasingly being played out through trade and economic ...

The company points to “emerging research” that shows GLP-1RA medications offer benefits beyond weight loss for patients ...

Norway's completed health tech assessments in 2025 were evaluated as positive, and raising thresholds may improve access conditions.

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

A sales probe from Organon's board has found evidence of wholesaler sales malpractice, resulting in Ali's resignation and a ...